Mitochondrial calcium stores (mCa2+) (mCa2+)

Mitochondrial calcium stores (mCa2+) refer to the accumulation of calcium ions within the mitochondrial matrix, a process primarily regulated by the Mitochondrial Calcium Uniporter (MCU) complex for uptake and the Sodium/Calcium/Lithium Exchanger (NCLX) for efflux (Rizzuto et al., 2012, Nature Reviews Molecular Cell Biology). These stores are vital for cellular bioenergetics, as calcium ions activate key rate-limiting enzymes in the tricarboxylic acid (TCA) cycle, including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, thereby coupling ATP production with cellular energy demand (Denton, 2009, Biochimica et Biophysica Acta). Beyond metabolism, mitochondrial calcium acts as a critical buffer for cytosolic calcium transients and plays a decisive role in determining cell fate; while physiological levels support survival, mitochondrial calcium overload is a primary trigger for the opening of the mitochondrial permeability transition pore (mPTP), leading to cytochrome c release and apoptosis (Giorgi et al., 2012, Trends in Cell Biology). Dysregulation of mitochondrial calcium homeostasis is a hallmark of various pathologies, including neurodegenerative diseases like Alzheimer's and Parkinson's, where calcium overload contributes to neuronal death, and cardiovascular diseases, where it mediates ischemia-reperfusion injury (Raffaello et al., 2016, Pflügers Archiv). Pharmacological strategies targeting mitochondrial calcium stores involve the use of MCU inhibitors (e.g., Ru360) to prevent overload or activators (e.g., kaempferol) to boost metabolism, though such interventions must carefully balance bioenergetic needs with the risk of toxicity (Woods et al., 2019, Cell Calcium).

Other names

Mitochondrial calcium poolMitochondrial matrix calciummCa2+Mitochondrial calcium

Modulation of mitochondrial calcium transport proteins (e.g., MCU, NCLX) to regulate matrix calcium concentration.